Exclusive: Thomas Cueni on 50 years of global progress
18.09.2018
Related Interviews
Access / Medicines Patent Pool Head on Mutual Benefits of Voluntary Licensing of Medicines in LMICs
The Medicines Patent Pool (MPP) is a United Nations-backed public health organisation working to increase access to, and facilitate the development of, life-saving medicines for low- and middle-income countries. Executive…
Bruno Delie – General Manager, Luye Pharma Switzerland
Luye Pharma is a China-headquartered fully integrated oncology and CNS specialist. Bruno Delie, general manager for Switzerland, discusses the organization’s ambitious European expansion plan, looking to establish affiliates in the…
Karin Blumer – Director Global Patient Engagement, Novartis Oncology
Karin Blumer, director of global patient engagement at Swiss giant Novartis, gives fascinating insights into the global patient advocacy landscape today and how Novartis interacts with it, the work being…
Switzerland / Nine Million Moderna Vaccines Destroyed; Historic Health Insurance Rise; Altamira all-in on RNA
The latest news from Swiss pharma and healthcare, including the startling announcement that Switzerland is set to destroy a full nine million doses of expired Moderna COVID-19 vaccines, with over…
Global / Roche Banking on M&A Spree to Rescale Pharma Rankings
Roche slipped from second to fifth place in this year’s ranking of the world’s top pharmaceutical companies, reported uninspiring numbers for the first half of the year and seen its…
Switzerland / Big Pharma Investment Continues with CHF 200 million from Takeda
After a Moderna-Lonza production site and a Merck manufacturing facility were set up in western Switzerland, the country continues to attract big pharma capital with a CHF 200 million investment…
